This week we're looking at a long setup in the Chemicals space.

We retired our "Five Bull Market Barometers" in mid-July to make room for a new weekly post that's focused on the three most important charts for the week ahead.

This is that post, so let's jump into this week's edition.

Remember when small and mid-Caps were the laggards?

Yea good times right?

Well, no mas my friends!

In this chart you can see the Large-cap growth stocks grouped to the upper left while the Small, Mids & Micro-caps are to the lower right.

Last week we discussed our improving views on the Nifty FMCG, focusing on Dixon Technologies. We followed up on that discussion with more info during our Members-Only Conference Call.

Our friends over at Bloomberg reached out to us for some updated analysis, so we wanted to share what we told them here.

We hope this helps reiterate our views on the sector.

The race for a cure is on!

Interest in stocks with direct and indirect exposure to the "vaccine trade" is through the roof. And with this interest comes some wild price action in both directions.

Today's play is in one of those names, but we like it more for its chart action than anything else. (It's kinda what we do here) ;)

We've been discussing the outperformance of Emerging Markets and since late October we've seen a massive rally in Equities around the globe.

Today we're taking a look at the indexes that help make up the majority of the Emerging Markets Index for context on their recent moves.

No, not those semis! Semiconductors!

We're seeing more and more long-term breakouts from monster bases and increasing relative strength across the entire sector.

Case in point, here's a chart of KLA Corp $KLAC:

From the desk of Steve Strazza @Sstrazza

Welcome to the 2 to 100 Club.

Something we’ve been working on internally this year is using various bottoms-up tools and scans to complement our top-down approach. One way we’re doing this is by identifying stocks as they climb the market-cap ladder from small, to mid, to large, and ultimately to mega-cap status (over $200B).

Once they graduate from small-cap to mid-cap status (over $2B) they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.

But the scan doesn’t just end there. We only want to look at the strongest growth industries in the market as that is typically where these potential 50-baggers come from.

Some of the best performers in recent decades – stocks like Priceline, Amazon, Netflix, and Salesforce, to a myriad of others… all would have been on this list at some point during their journey to becoming the market behemoths they are today.

When you look at the stocks in our table you will notice we are only...

From the desk of Steve Strazza @Sstrazza

New Mystery Chart!

For those new to this exercise, we take a chart of interest and remove the x/y-axes and any other labels that would help identify it. The chart can be any security in any asset class on any timeframe on an absolute or relative basis. Maybe it’s a custom index or inverted, who knows!

We do all this to put aside the biases we have associated with this specific security/the market and come to a conclusion based solely on price.

You can guess what it is if you must, but the real value comes from sharing what you would do right now. Buy, Sell, or Do Nothing?

From the desk of Steve Strazza @Sstrazza.

Tuesday night we held November’s Monthly Conference Call which our Premium Members can access and rewatch here.

In this post, we’ll provide a summary of the call by highlighting 5 of the most important charts/topics we covered along with commentary on each.

Let’s dive into it.

This is the video recording of the November 2020 Conference Call.